MIG
ARIA

Mariner Investment Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Mariner Investment Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-40,000
Closed -$8K – 333
2014
Q3 		$8K Buy
+40,000
New +$234K ﹤0.01% 237

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Mariner Investment Group's ARIA Position: Q3 2016 in Review

Mariner Investment Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 169,000 shares — an estimated $1.25M sold.

Mariner Investment Group first reported a position in ARIA in Q1 2014 and held it in 10 quarters. The position peaked at $2.16M in Q2 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Mariner Investment Group reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 169,000 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $1.25M.
  • Mariner Investment Group first reported a position in Ariad Pharmaceuticals Inc in Q1 2014 and held it in 10 quarters.
  • Mariner Investment Group's Ariad Pharmaceuticals Inc position peaked at $2.16M in Q2 2014.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.